Ignite Creation Date:
2025-12-24 @ 3:00 PM
Ignite Modification Date:
2026-02-25 @ 12:53 AM
Study NCT ID:
NCT00558259
Status:
COMPLETED
Last Update Posted:
2014-06-27
First Post:
2007-11-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-11
Start Date Type:
None
Primary Completion Date:
2011-02
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2007-11-13
First Submit QC Date:
None
Study First Post Date:
2007-11-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-01-31
Results First Submit QC Date:
None
Results First Post Date:
2012-03-02
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-06-17
Last Update Post Date:
2014-06-27
Last Update Post Date Type:
ESTIMATED